School of Medicine


Showing 1-35 of 35 Results

  • Laura Michele Hack

    Laura Michele Hack

    Assistant Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)

    BioDr. Laura Hack is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences, Director of Novel & Precision Neurotherapeutics at the Stanford Center for Precision Mental Health and Wellness, Director of the Stanford Translational Precision Mental Health Clinic, and Deputy Director of the Precision Neuromodulation Clinic (PNC) within the VA Palo Alto Health Care System. Dr. Hack's translational research program focuses on identifying bioclinical subtypes of depression and testing mechanistically-guided treatments for these subtypes. Dr. Hack studies treatments spanning repurposed medications, such as pramipexole and guanfacine, neuromodulation techniques, ketamine, MDMA, and psilocybin. Clinically, she specializes in delivering novel treatments, including repetitive transcranial magnetic stimulation (rTMS) and ketamine, to patients suffering from treatment-resistant depression and comorbid trauma-related disorders.

  • Scott S. Hall, Ph.D

    Scott S. Hall, Ph.D

    Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Sciences)

    Current Research and Scholarly InterestsMy primary area of scholarly and clinical interest is the pathogenesis of problem behaviors shown by individuals diagnosed with intellectual and developmental disabilities (IDD), particularly those with neurogenetic forms of IDD, such as fragile X syndrome, Cornelia de Lange syndrome and Prader-Willi syndrome. My work aims to both advance understanding of these disorders and to identify effective new treatment approaches for pediatric and adult patient populations by state-of-the-art methodologies, such as brain imaging, eye tracking and functional analysis to determine how environmental and biological factors affect the development of aberrant behaviors in these syndromes. The end goal of my research is to create patient-specific methods for treating the symptoms of these disorders.

  • Joachim Hallmayer

    Joachim Hallmayer

    Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsPrincipal Investigator
    Infrastructure to facilitate discovery of autism genes
    The purpose of this project is to facilitate the discovery of the genes that contribute autism by maintaining an infrastructure which research groups studying the genetics of autism can work collaboratively. This will be
    accomplished through workshops, a Virtual Private Network, and access to a database that includes phenotype and genotype data from all participating groups.

    Principal Investigator
    A California Population-Based Twin Study of Autism
    This will address several fundamental questions: (1) What is the heritability of autism (2) What is the contribution of genetic factors to variation in symptom dimensions? (3) Is there a continuum between the quantitative neurocognitive traits and clinical disorder? (4) What proportion of the variance in the neurocognitive traits is accounted for by genetic and non-genetic factors?

    Co-Investigator
    Center for Integrating Ethics in Genetics Research(Cho)
    The goal of this project is to serve as a center of excellence in neurogenetics research, to develop a national model for bench, to bedside research ethics consultation, and to provide training opportunity in biomedical ethics.

    Co-Investigator
    Gene, Brain and Behavior in Turner Syndrome(Reiss)
    The primary objective of this project is to use advanced, multi-modal magnetic resonance imaging (MRI) techniques, analyses of X chromosome parent-of-origin and cognitive-behavioral assessment to elucidate the effects of monosomy and X-linked imprinting on neurodevelopment and neural function in a large cohort of young girls with Turner syndrome, pre-estrogen replacement.

    Project Director
    Project F: Genomic Analysis in narcolepsy cataplexy
    The goal of the project is to locate genes outside the HLA region that influence susceptibility to narcolepsy. In order to localize these genes we will carry out a linkage and association study in the most extensive world-wide collection of DNAs from well-characterized patients with narcolepsy and their families.

  • Bonnie Halpern-Felsher

    Bonnie Halpern-Felsher

    Marron and Mary Elizabeth Kendrick Professor of Pediatrics and Professor, by courtesy, of Epidemiology and Population Health and of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsResearch focuses on developmental, cognitive and psychosocial factors involved in adolescents’ and young adults’ health-related decision-making, perceptions of risk and vulnerability, health communication and risk behavior. My research has focused on understanding and reducing health risk behaviors such as tobacco use, alcohol and marijuana use, risky driving, and risky sexual behavior.

  • Antonio Hardan, M.D.

    Antonio Hardan, M.D.

    Professor of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsThe neurobiology of autism
    Neuroimaging in individuals with autism
    Psychopharmacological treatment of children and adults with autism and/or developmental disorders
    The neurobiology and innovative interventions of several neurogenic disorders including DiGeorge Syndrome (Velocardiofacial syndrome; 22q11.2 mutations), PTEN mutations, and Phelan McDermid Syndrome (22q13 mutations).

  • Kate Hardy

    Kate Hardy

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioKate Hardy is a California Licensed Psychologist who has specialized in working with individuals with psychosis for over 15 years in both research and clinical settings. Dr. Hardy received her doctorate in clinical psychology from the University of Liverpool, United Kingdom. She has worked in specialist early psychosis services in both the UK and the US, including UCSF’s Prodrome Assessment Research and Treatment (PART) program, where she completed her post-doctoral fellowship, and as Clinical Director for the Prevention and Recovery from Early Psychosis (PREP) program. Dr. Hardy has significant experience in providing CBTp to individuals with early psychosis, and those at risk of developing psychosis, in both individual and group settings and integration of this clinical intervention to broader systems and staff teams. She has led multiple trainings and workshops in CBTp to a wide variety of audiences including community clinicians, psychiatrists, and families, and provides ongoing supervision and consultation in this approach. Dr. Hardy is also involved in the implementation of national strategies to increase dissemination of early psychosis models with the aim of bringing these cutting edge treatments to a broader population.

  • Nancy A. Haug

    Nancy A. Haug

    Adjunct Clinical Professor, Psychiatry and Behavioral Sciences

    BioNancy A. Haug, PhD is Adjunct Clinical Professor and Addiction Medicine fellowship program faculty in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine. She currently leads didactics and a journal club for Addiction Medicine fellows, and teaches a postdoctoral seminar on ethics and legal issues for the Clinical Psychology Fellowship Program. Dr. Haug's primary academic affiliation is Professor of Psychology at Palo Alto University, where she teaches, advises and supervises doctoral students in the PGSP-Stanford PsyD Consortium. Dr. Haug previously served as faculty and attending psychologist in the Department of Psychiatry at the University of California San Francisco, and taught in the University of California, Berkeley Alcohol & Drug Studies program. She obtained her PhD in Clinical Psychology and Behavioral Medicine at the University of Maryland, Baltimore County and a Master's degree in Counseling Psychology at Loyola University, Maryland. She completed a clinical internship and postdoctoral fellowship at University of California, San Francisco and San Francisco General Hospital in public service and minority mental health.

    Dr. Haug is a member of the American Psychological Association (APA) Ethics Committee and formerly served as a member of the California Psychological Association Ethics Committee. She is a Fellow and Member-at-Large for Practice in the Society of Addiction Psychology (APA, Division 50). Dr. Haug is on the editorial board of the Journal of Psychoactive Drugs and the Journal of Addictive Diseases. She was funded by SAMHSA for a practitioner-education initiative to expand training for evidence-based addiction treatment. Dr. Haug leads the Harm Reduction and Addiction Treatment Laboratory at PAU with current research studies on the implementation of evidence-based practices in addiction treatment, harm reduction for substance use, cannabis vaping and psychedelic-assisted psychotherapy.

    Dr. Haug has been licensed as a psychologist in California since 2004, is board certified in addiction psychology by American Board of Professional Psychology, and has an independent practice in Los Gatos, CA. She has clinical expertise in treating substance misuse and eating disorders using motivational interviewing, cognitive-behavioral and mindfulness-based therapies including Acceptance and Commitment Therapy. Dr. Haug is a Stanford WellConnect referral for fellows, residents and faculty in her clinical practice. She recently completed the Stanford YogaX 200-Hour Yoga Teacher Training Program with healthcare setting emphasis.

  • John P. Hegarty II

    John P. Hegarty II

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioI am a neuroscientist and Principal Investigator of the Stanford Clinical Neuroscience (CNS) Lab in the Department of Psychiatry and Behavioral Sciences as well as Director of Neuroimaging for the Autism and Developmental Disorders Research Program at Stanford. My innovative research studies clinical aspects of cognitive and behavioral neuroscience, with a special focus on examining the neural circuitry associated with important brain-behavior relationships that may underlie different psychological and psychiatric domains in autistic children, adolescents, and adults. The ultimate goal of this research is to improve our understanding of the development of different cognitive and behavioral skills in order to develop mechanistically driven interventions that will improve precision medicine for mental health. Biologically based diagnosis and treatment are extremely limited for most psychological and psychiatric conditions but also critically needed to increase early identification and improve treatment outcomes, especially for neurodevelopmental disorders in which early intervention is the most beneficial. My early career research has primarily focused on clinical neuroscience using neuroimaging (e.g., MRI & EEG) to examine the effects of different drugs and behavioral interventions on the brain, especially for developing biomarkers for improving treatment planning and monitoring biological changes in response to single dose and clinical trials.

    My primary contributions to science thus far fall within these major categories: 1) identifying the neural correlates of individual differences in cognition and behavior, 2) developing new interventions and investigating the neurobiological substrates of response to treatment, 3) examining different factors that contribute to brain development, 4) summarizing and increasing accessibility to autism-related research, and 5) methods development for neuroimaging studies. My earliest research investigated the neurobiology of alexithymia, dyslexia, and stress using structural and functional magnetic resonance imaging to test theories of the mechanisms that contribute to differences in cognition and behavior. My subsequent dissertation research, in which I began to focus on neurodevelopmental disorders, examined the neural correlates of response to beta-blockers in autistic adults and also assessed the contribution of cerebellar circuits to the autism phenotype. During my postdoctoral training, I have developed further skills for working with children in multiple clinical research settings, especially for using advanced neuroimaging approaches to examine important brain-behavior relationships. This includes a recent K99/R00 from the National Institute of Child Health and Human Development (NCT04278898 & NCT05664789) that will assess the neurobiology of restricted and repetitive behaviors in autistic children and examine the efficacy and target engagement of a novel nutritional supplement and investigational drug, N-acetylcysteine (NAC), in the brain. You can find more information about our NAC studies at https://redcap.link/NACandAutism.

  • Kimberly Hill

    Kimberly Hill

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Hill received her Ph.D. in Clinical Psychology from Ohio University. She completed her doctoral internship at the Veterans Affairs Palo Alto Health Care System and postdoctoral fellowship in the Psychiatry Department at the Stanford University School of Medicine where she currently serves as a Clinical Professor. Dr. Hill has published articles and made presentations related to psychology training, pain management, serious mental illness including Post Traumatic Stress Disorder, and sexual dysfunction.

    Dr. Hill's time is divided across clinical, research, administrative, and teaching domains. Her current clinical interests are varied including anxiety, mood disorders, relationship difficulties, and post-traumatic stress disorder. The bulk of her time is committed to psychology training as the Director of Clinical Training for the PGSP-Stanford Psy.D. Consortium. On a national level, she currently serves as the Vice Chair of the Association of Psychology Postdoctoral and Internship Centers (APPIC).

  • Melanie Hom

    Melanie Hom

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences

    BioDr. Melanie Hom is a Clinical Assistant Professor and attending psychologist in the Anxiety and Depression Adult Psychological Treatment (ADAPT) Clinic, Dialectical Behavior Therapy (DBT) Clinic, and Stanford Mental Health for Asians Research and Treatment (SMHART) Clinic. She utilizes evidence-based therapies, including acceptance and commitment therapy (ACT), cognitive behavioral therapy (CBT), and DBT. Dr. Hom also strives to provide culturally informed psychotherapy in her work with individuals, couples, and families. Her research interests include (1) enhancing help-seeking and treatment engagement among individuals at elevated suicide risk and (2) improving mental health care services for Asians and Asian Americans.

  • David S. Hong

    David S. Hong

    Associate Professor of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)

    Current Research and Scholarly InterestsDr. Hong is a child and adolescent psychiatrist and clinician-scientist. His responsibilities span clinical care, teaching/mentorship, and research, with a unifying theme of advancing a developmental cognitive framework as applied to psychiatric conditions. Using this core premise, he work encompasses multiple domains: specialized clinical care, fellowship training, research mentorship, and elaborating the role of sex-specific determinants of development, one of the greatest contributors to individual developmental variation.

    His lab investigates genetic and hormonal influences underlying sex differences in child psychiatric conditions. Sex has emerged as a critical variable driving differences in the phenomenology, course, and treatment of many mental health disorders. Unfortunately, an understanding of the biological mechanisms driving these effects are limited. By applying innovative neuroimaging and multiomic approaches, Dr. Hong seeks to provide a deeper understanding of the connection between sex-specific effects and complex psychiatric diseases. To do so, research in the Hong Lab focuses on the role of genes on the X and Y chromosomes, as well as circulating sex hormones on brain development, cognition, and behavior. The lab broadly aims to elucidate the changing nature of these mechanisms across various stages of development.

    Another area of focus is the implementation of clinical informatics in child psychiatry and the development of digital mental health tools. As co-Director of the Mental Health Technology and Innovation Hub, Dr. Hong is helping to develop clinical and research infrastructure within the Department of Psychiatry and Behavioral Sciences to advance development of mobile mental health resources that will improve efficacy and access to mental health care.

  • Janie Hong, Ph.D.

    Janie Hong, Ph.D.

    Clinical Associate Professor, Psychiatry and Behavioral Sciences

    BioDr. Hong is invested in developing evidence-based ways to individualize care and address diversity factors in therapy and in training fellows and residents in these approaches. She has published and presented widely on these and other topics in psychology.

    In clinical practice, she specializes in providing cognitive behavior therapy (CBT) and other evidence based treatments. She is also committed to helping neurodiverse and culturally diverse individuals work with their differences, navigate prevailing social norms, and advocate for their needs as diverse individuals.

  • Korey Hood

    Korey Hood

    Professor of Pediatrics (Endocrinology) and of Psychiatry and Behavioral Sciences (Child and Adolescent Psychology)

    BioDr. Hood directs NIH- and foundation-funded clinical research aimed at promoting health and quality of life outcomes for people with diabetes. He has expertise and experience with diabetes epidemiology and interventions, study design, methodology, data management, and advanced statistical methods. There are two content threads to his work: 1) construct prevention and treatment programs to address modifiable psychological and family factors that create barriers to optimal diabetes management, and 2) optimize the use of devices and technologies to improve health outcomes. With regard to the first thread, Dr. Hood has successfully implemented depression screening programs in tertiary diabetes and GI clinics within a Quality Improvement framework, and recently completed a large scale clinical trial on a distress prevention program for teens with type 1 diabetes. Dr. Hood manages and analyzes all the data from these studies. From a device and technology standpoint, Dr. Hood coordinates the Human Factors assessments in Drs. Maahs’ and Buckingham’s closed loop studies and is recognized as one of the experts in this area nationally and internationally. In addition, he has implemented Human Factors assessments in national (e.g., T1D Exchange) studies and registries and is the lead psychologist on 2 of the 4 UC4 grants from NIDDK (Hovorka, PI; Bergenstal, PI). These assessments focus on uptake of devices and technologies, and determining strategies to promote uptake and optimize their use. Dr. Hood and his research team have published over 100 scientific articles on these topics and are active presenters at diabetes, behavioral medicine, and advocacy conferences.

    Dr. Hood also works in clinical and service settings. Dr. Hood is a licensed clinical psychologist and is part of the diabetes care team at Stanford. He is the past chair of the American Diabetes Association’s Behavioral Medicine and Psychology Interest Group and is currently a member of the Research Policy Committee. He was also a member of the ADA’s Call to Congress in March 2017. Dr. Hood is an Associate Editor for both Diabetes Care and Pediatric Diabetes.

  • Benjamin Joseph Hoover

    Benjamin Joseph Hoover

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry

    BioDr. Hoover graduated with a BS in Biology and a minor in Chemistry from Duke University. After his undergraduate studies, he joined the Leppla Laboratory at the National Institutes of Health as an Intramural Research Training Awardee. While there, he investigated the use of engineered anthrax toxin as a chemotherapeutic, and he graduated from the NIH Academy, with extensive coursework in health disparities. Then he returned to the Duke University School of Medicine, where he earned his MD in 2017. While in medical school, his interest in infectious disease evolved into curiosity about the gut-brain axis. He investigated gut sensation and its role in behavior using 3D electron microscopy, ultimately publishing a novel characterization of tuft cell ultrastructure.

    Given his growing interest in behavior, Dr. Hoover pursued psychiatry residency at the MGH McLean program. During this time, he was accepted into the R-25 funded Physician Scientist Training Program and joined the Kahn Laboratory at the Joslin Diabetes Center. He employed an iPSC model to investigate the role of insulin signaling dysfunction in Alzheimer’s Disease pathogenesis. His clinical interests also began to focus on the intersection of medical and psychiatric disease. He served as a chief resident and won the Anne Alonso Award for Psychotherapy and the Residency Neuroscience Award. After residency, he was accepted into the MGH Consultation-Liaison Psychiatry Fellowship.

    After graduating from fellowship in 2022, Dr. Hoover joined the Stanford University School of Medicine faculty as a Clinical Assistant Professor of Psychiatry. As part of the Medical Psychiatry division, he consults on hospitalized patients with psychiatric comorbidities within intensive care units and general medical and surgical floors. The interface between endocrinology and psychiatry remains a particular area of clinical and research interest, and he brings years of previous laboratory experience in this area to his clinical practice.

  • Valerie Hoover

    Valerie Hoover

    Adjunct Clinical Instructor, Psychiatry and Behavioral Sciences

    BioValerie Hoover, PhD is a Licensed Clinical Psychologist in California who specializes in the assessment and treatment of anxiety disorders, stress management and recovery, trauma and PTSD, interpersonal issues, and psychological adjustment following medical events. Dr. Hoover is also an expert in motivational enhancement and is a MINT-Certified Motivational Interviewing trainer.

    Dr. Hoover completed a doctorate in Clinical Psychology with an emphasis in Health Psychology at the University of Florida in 2013, then went on to complete her clinical residency at Rush University Medical Center in Chicago and post-doctoral fellowship at the San Francisco VA Medical Center.

    Dr. Hoover is passionate about helping people make meaningful and durable changes in their lives.

  • Hadi Hosseini

    Hadi Hosseini

    Associate Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)

    Current Research and Scholarly InterestsOur lab’s research portfolio crosses multiple disciplines including computational neuropsychiatry, cognitive neuroscience, multimodal neuroimaging and neurocognitive rehabilitation. Our computational neuropsychiatry research mainly involves investigating alterations in the organization of connectome in various neurodevelopmental and neurocognitive disorders using state of the art neuroimaging techniques (fMRI, sMRI, DWI, functional NIRS) combined with novel computational methods (graph theoretical and multivariate pattern analyses).

    The ultimate goal of our research is to translate the findings from computational neuropsychiatry research toward developing personalized interventions. We have been developing personalized interventions that integrate computerized cognitive rehabilitation, real-time functional brain imaging and neurofeedback, as well as virtual reality (VR) tailored toward targeted rehabilitation of the affected brain networks in patients with neurocognitive disorders.

  • Kristene Hossepian

    Kristene Hossepian

    Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development

    BioDr. Kristene Hossepian is a licensed clinical psychologist with expertise in anxiety, depression, eating disorders, parent management training, and stress. During her doctorate training at the PGSP-Stanford Psy.D. Consortium she received extensive training in a number of evidence-based treatment approaches for children and adolescents, such as Cognitive Behavioral Therapy, Dialectical Behavioral Therapy, and Acceptance and Commitment Therapy. She completed her pre-doctoral internship at Lucile Packard Children’s Hospital/Children’s Health Council where she worked with youth struggling with severe eating disorders, chronic medical conditions, trauma, depression, and anxiety. After receiving her doctorate in 2020, Dr. Hossepian completed her postdoctoral fellowship at the Stanford University School of Medicine, where she continued to receive training in evidence-based treatments for youth with a variety of presenting problems at the inpatient and outpatient level.

    Currently, Dr. Hossepian is a Clinical Assistant Professor within the Division of Child and Adolescent Psychiatry at the Stanford University School of Medicine. She works alongside Dr. Mary Sanders and Dr. Jennifer Derenne at the Comprehensive Care Program serving children and adolescents who are medically compromised due to complications with their eating disorders. Additionally, Dr. Hossepian works within Dr. Victoria Cosgrove’s Stress, Resilience, Emotion, and Mood (StREam) Laboratory to identify the ways that psychobiological stress responsivity is implicated in the emergence and propagation of affective symptomatology. Dr. Hossepian is interested in exploring the physiological mechanisms underlying mood disorders and eating disorders as well as providing children and adolescents with novel emotion regulation strategies.

  • Rona Hu

    Rona Hu

    Clinical Professor, Psychiatry and Behavioral Sciences

    BioDr. Hu is Medical Director of the Acute Psychiatric Inpatient Unit at Stanford Hospital, specializing in the care of those with serious mental illnesses, including schizophrenia, bipolar and depression. She completed medical school and residency in psychiatry at the University of California, San Francisco, and fellowships in Pharmacology and Schizophrenia Research through the National Institutes of Health. She is also active in the minority issues and cultural psychiatry, and has received regional and national recognition for her clinical care, research and teaching.

  • Andrew D. Huberman

    Andrew D. Huberman

    Associate Professor of Neurobiology and, by courtesy, of Psychiatry and Behavioral Sciences

    Current Research and Scholarly InterestsIn 2017, we developed a virtual reality platform to investigate the neural and autonomic mechanisms contributing to fear and anxiety. That involved capturing 360-degree videos of various fear-provoking situations in real life for in-lab VR movies, such as heights and claustrophobia, as well as unusual scenarios like swimming in open water with great white sharks. The primary objective of our VR platform is to develop new tools to help people better manage stress, anxiety and phobias in real-time, as an augment to in-clinic therapies.

    In May 2018, we reported the discovery of two novel mammalian brain circuits as a Research Article published in Nature. One circuit promotes fear and anxiety-induced paralysis, while the other fosters confrontational reactions to threats. This led to ongoing research into the involvement of these brain regions in anxiety-related disorders such as phobias and generalized anxiety in humans.

    In 2020, we embarked on a collaborative effort with Dr. David Spiegel's laboratory in the Stanford Department of Psychiatry and Behavioral Sciences, aimed to explore how specific respiration patterns synergize with the visual system to influence autonomic arousal and stress, and other brain states, including sleep.

    In 2023, the first results of that collaboration were published as a randomized controlled trial in Cell Reports Medicine, demonstrating that specific brief patterns of deliberate respiration are particularly effective in alleviating stress and enhancing mood, and improving sleep.

    In a 2021, our collaboration with Dr. Edward Chang, professor and chair of the Department of Neurological Surgery at the University of California, San Francisco (UCSF), was published in Current Biology, revealing that specific patterns of insular cortex neural activity may be linked to, and potentially predict, anxiety responses.

  • Lynne C. Huffman

    Lynne C. Huffman

    Professor (Teaching) of Pediatrics (Developmental-Behavioral Pediatrics) and, by courtesy, of Psychiatry and Behavioral Sciences
    On Partial Leave from 02/01/2024 To 08/31/2025

    Current Research and Scholarly InterestsResearch interests and activities include (1) shared decision-making in clinical care; (2) medical education research; (3) the early identification and treatment of behavioral problems, particularly in children with special health care needs; and (4) community-based mental health/educational program evaluation and outcomes measurement.

  • Keith Humphreys

    Keith Humphreys

    Esther Ting Memorial Professor

    Current Research and Scholarly InterestsDr. Humphreys researches individual and societal level interventions for addictive and psychiatric disorders. He focuses particularly on evaluating the outcomes of professionally-administered treatments and peer-operated self-help groups (e.g., Alcoholics Anonymous), and, analyzing the impact of public policies touching addiction, mental health, public health, and public safety.

  • Filza Hussain

    Filza Hussain

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry

    BioDr. Hussain completed her medical education in Karachi, Pakistan, at the Aga Khan University in 2005 and travelled to the US to pursue her interest in Psychiatry. During residency at the Mayo Clinic, Minnesota she was awarded the Mayo clinic M.J Martin award for excellence in CL psychiatry. It was at Mayo that she solidified her interest and identity as a Consultation Liaison Psychiatrist. Eliminating Mind body dualism while educating others and addressing stigma against psychiatry seemed like an effortless choice and so she pursued a CL fellowship at Columbia University in New York.
    Visa obligations took her first to the UK where she utilized her experience in evaluating CL service performance in large teaching hospitals in the NHS. She subsequently moved back to the US to serve as the sole outpatient provider for eleven different counties in Northwest Wisconsin with a panel of over 1500 patients at a Mayo clinic satellite. During this time, she was an active board member of NAMI, taught psychopathology in Crisis Intervention Training for the Eau Claire, and Chippewa Police departments and avidly contributed to international health blogs and newspaper articles with an aim to decrease stigma against psychiatry
    In Pursuit of a stimulating academic environment and a return to her true passion, CL psychiatry, she joined Stanford as a Clinical Assistant Professor at Stanford University School of Medicine in 2017. As member of the Education Committee and as of 2022, the CLP Fellowship Associate Program Director, She has been active in helping to restructure the fellowship education experience, initiating several new seminars including the immersion series, the book seminar, and organizing the Chief of service rounds. Her clinical focus is transplant psychiatry, and she serves as the liaison to the Liver and Kidney transplant programs at Stanford. She continues to be engaged with the community and currently participates in the Liver Education and Awareness Program(LEAP) , an endeavor educating patients about Fatty Liver disease. Other areas of clinical/research interests include Personality disorders, Suicidology, Cultural Psychiatry and medical pedagogy. She is also working with Dr. Maldonado in developing the SIPAT-D, a tool for evaluation of live organ donors.